Comparison of screening procedures in hydroxychloroquine toxicity
- PMID: 22159170
- DOI: 10.1001/archophthalmol.2011.371
Comparison of screening procedures in hydroxychloroquine toxicity
Abstract
Objectives: To compare different screening procedures for hydroxychloroquine sulfate (Plaquenil) toxicity at different stages of damage.
Methods: Ten patients were studied using 10-2 automated fields, multifocal electroretinography, spectral domain optical coherence tomography (SD-OCT), and fundus autofluorescence.
Results: All 10 patients used hydroxychloroquine for more than 6 years, and those with severe toxicity had been overdosed. Fundus examination findings were normal except for the patients with severe toxicity. All the patients showed parafoveal field loss, but this was sometimes subtle. Multifocal electroretinography demonstrated parafoveal weakness in the milder cases. The SD-OCT subfield thickness plots showed a ring of parafoveal thinning in all the patients. The SD-OCT cross-sections showed parafoveal loss of the inner segment-outer segment and cone outer segment tip lines at early stages of toxicity, progressing to parafoveal thinning of the outer nuclear layer and eventually to retinal pigment epithelium damage. There was a ring of autofluorescence in most patients.
Conclusions: Overdosage with hydroxychloroquine seemed a significant risk factor for toxicity. Different individuals were more or less sensitive to different tests. Fields can be sensitive but only if read with a low threshold for change. Hydroxychloroquine causes early parafoveal loss of the outer segment lines on SD-OCT, with the first changes often evident in the inferotemporal quadrant. Parafoveal thinning of the outer nuclear layer follows, before retinal pigment epithelium damage is visible. Careful screening with multiple tests can detect toxic damage before prominent loss of the outer nuclear layer.
Similar articles
-
Effect of disease stage on progression of hydroxychloroquine retinopathy.JAMA Ophthalmol. 2014 Sep;132(9):1105-12. doi: 10.1001/jamaophthalmol.2014.1099. JAMA Ophthalmol. 2014. PMID: 24922444
-
Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.Ophthalmology. 2014 Jun;121(6):1257-62. doi: 10.1016/j.ophtha.2013.12.002. Epub 2014 Jan 16. Ophthalmology. 2014. PMID: 24439759
-
Subjective and objective screening tests for hydroxychloroquine toxicity.Ophthalmology. 2015 Feb;122(2):356-66. doi: 10.1016/j.ophtha.2014.07.056. Epub 2014 Oct 14. Ophthalmology. 2015. PMID: 25444344 Free PMC article.
-
Hydroxychloroquine: A Brief Review on Screening, Toxicity, and Progression.Ophthalmic Surg Lasers Imaging Retina. 2016 Mar;47(3):207-17. doi: 10.3928/23258160-20160229-02. Ophthalmic Surg Lasers Imaging Retina. 2016. PMID: 26985794 Review. No abstract available.
-
Hydroxychloroquine retinopathy: A review of imaging.Indian J Ophthalmol. 2015 Jul;63(7):570-4. doi: 10.4103/0301-4738.167120. Indian J Ophthalmol. 2015. PMID: 26458473 Free PMC article. Review.
Cited by
-
Coding patterns used by ophthalmologists for hydroxychloroquine retinal toxicity.Clin Ophthalmol. 2018 Nov 5;12:2261-2265. doi: 10.2147/OPTH.S170789. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30464387 Free PMC article.
-
Clock-hour topography and extent of outer retinal damage in hydroxychloroquine retinopathy.Sci Rep. 2022 Jul 12;12(1):11809. doi: 10.1038/s41598-022-15217-3. Sci Rep. 2022. PMID: 35821509 Free PMC article.
-
Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy.Clin Ophthalmol. 2014 Jul 25;8:1389-99. doi: 10.2147/OPTH.S66527. eCollection 2014. Clin Ophthalmol. 2014. PMID: 25114499 Free PMC article.
-
Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy.Diagnostics (Basel). 2023 May 16;13(10):1752. doi: 10.3390/diagnostics13101752. Diagnostics (Basel). 2023. PMID: 37238236 Free PMC article. Review.
-
Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.J Korean Med Sci. 2017 Mar;32(3):522-527. doi: 10.3346/jkms.2017.32.3.522. J Korean Med Sci. 2017. PMID: 28145658 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical